USPTO serial 79290978
BEAT
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- Jan 18, 2022
- Examiner
- MESSICK, TABITHA LEE
- Law office
- PUBLICATION AND ISSUE SECTION
What this means
Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.
Need help with BEAT?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Jeffrey H. Greger
Jeffrey H. Greger Hauptman Ham, LLP2318 Mill Rd.Suite 1400Alexandria, VA 22314Goods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 001 | Chemical products used in industry and science as well as in agriculture, horticulture and forestry, particularly laboratory chemicals, biochemicals in the nature of antibodies, trimeric antibodies and derivatives thereof, all for use in the development or manufacture of immunological reagents for industrial and scientific use; laboratory chemicals, biochemicals in the nature of antibodies, trimeric antibodies and derivatives thereof for laboratories, diagnostics and analytics for scientific or research use; chemical preparations for industrial and scientific use | ACTIVE | — |
| 005 | Medical preparations, namely, antibodies, trimeric antibodies and derivatives thereof, for the treatment of cancer, allergies, asthma, autoimmune diseases, inflammation, graft versus host diseases, inflammation, transplant rejection, infectious diseases, bone diseases, heart diseases, endocrine diseases, eye diseases, intestinal diseases and neurological diseases, in the form of parenteral, intravitreal, intra-peritoneal and aerosol therapies; medical preparations, namely, antibodies for diagnostic or therapeutic use and for use in assays | ACTIVE | — |
| 009 | Scientific, weighing, measuring, checking, supervision and teaching apparatus and instruments for scientific laboratory research in the field of antibodies, trimeric antibodies and derivatives thereof, namely, laboratory equipment for purifying, detecting and analysing antibodies, trimeric antibodies and derivatives thereof | ACTIVE | — |
| 010 | Medical apparatus and instruments in the nature of medical devices and instruments to purify, detect and analyse antibodies, trimeric antibodies and derivatives thereof from patient samples who have a respiratory conditions; spirometers; medical devices in the nature of medical devices and instruments to purify, detect and analyse antibodies, trimeric antibodies and derivatives thereof from patient samples from body fluid samples; means of administration of medicinal products such as inhalers and nasal spray nebulizers; Medical apparatus and instruments in the nature of syringes for medical purposes; medical devices and instruments to purify, detect and analyse antibodies , trimeric antibodies and derivatives thereof from patient blood samples; diagnostic apparatus for medical use for detection of cancer | ACTIVE | — |
| 035 | Developing promotional campaigns for patient support programs | ACTIVE | — |
| 042 | Medical research, namely, laboratory research in the field of antibodies, trimeric antibodies and derivatives thereof; product development in the field of medicines, namely, antibodies, trimeric antibodies and derivatives thereof; product development in the field of diagnostic and testing apparatus and instruments for the identification of diseases, namely, antibodies, trimeric antibodies and derivatives thereof; industrial research in the field of antibodies, trimeric antibodies and derivatives thereof; analysis of antibodies, trimeric antibodies and derivatives thereof in the nature of industrial analysis; contract research services in the field of antibodies, trimeric antibodies and derivatives thereof | ACTIVE | — |
| 044 | Medical services, medical clinics, medical assistance; consulting services in the field of healthcare, oncology, pain management, dermatology, diabetology, respiratory diseases and dietetic advisory services in the nature of pharmacy advice; hygienic and beauty care for human beings or animals; veterinary services; agriculture, horticulture and forestry services, namely, compost spreading; providing information in the field of medicine and health | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by Ichnos Sciences SA
- Other trademarks owned by Ichnos Sciences SA
- Other trademarks owned by Ichnos Sciences SA
- Other trademarks in Class 001
- Other trademarks in Class 005
- Other trademarks in Class 009
- Other trademarks in Class 010
- Other trademarks in Class 035
- Other trademarks in Class 042
- Other trademarks in Class 044
- Similar marks named BEAT
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Jul 18, 2022 | FINO | FINAL DECISION TRANSACTION PROCESSED BY IB | — |
| Jun 28, 2022 | FICS | FINAL DISPOSITION NOTICE SENT TO IB | — |
| Jun 27, 2022 | FIMP | FINAL DISPOSITION PROCESSED | — |
| Apr 18, 2022 | FICR | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | — |
| Jan 29, 2022 | OPNX | NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB | — |
| Jan 18, 2022 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Jan 12, 2022 | OPNS | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | — |
| Jan 12, 2022 | OPNR | NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB | — |
| Nov 8, 2021 | GPNX | NOTIFICATION PROCESSED BY IB | — |
| Nov 2, 2021 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Nov 2, 2021 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Oct 13, 2021 | OPNS | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | — |
| Oct 13, 2021 | OP2R | NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB | — |
| Oct 13, 2021 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Sep 25, 2021 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Sep 17, 2021 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Sep 17, 2021 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Sep 17, 2021 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Mar 30, 2021 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Mar 30, 2021 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Mar 30, 2021 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Mar 6, 2021 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Mar 5, 2021 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Mar 5, 2021 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Nov 7, 2020 | NREP | NEW REPRESENTATIVE AT IB RECEIVED | — |
| Oct 19, 2020 | RFNT | REFUSAL PROCESSED BY IB | — |
| Sep 25, 2020 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| Sep 25, 2020 | RFRR | REFUSAL PROCESSED BY MPU | — |
| Sep 3, 2020 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Sep 2, 2020 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Aug 31, 2020 | DOCK | ASSIGNED TO EXAMINER | — |
| Aug 11, 2020 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Aug 7, 2020 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Aug 6, 2020 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |